Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 13/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | RUNX1 | Q01196 | 2/20 | 0.40 |
| ▸ | CBFB | Q13951 | 2/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12906161 | 0.71 | NOTUM (0.59) | NOTUMMAPTALDH1A1HTTHPGD | |
| SCHEMBL22015413 | 0.69 | HPGDS (0.37) | MAPTALDH1A1HTTGAAHPGD | |
| SCHEMBL262142 | 0.65 | KDM4E (0.49) | NOTUMMAPTALDH1A1GAAHPGD | |
| SCHEMBL22738890 | 0.65 | NOTUM (0.48) | NOTUMMAPTALDH1A1HTTHPGD | |
| SCHEMBL7255351 | 0.64 | NOTUM (0.38) | NOTUMMAPTALDH1A1HTTHPGD | |
| SCHEMBL20016442 | 0.64 | NOTUM (0.42) | NOTUMMAPTALDH1A1HTTHPGD | |
| SCHEMBL3412890 | 0.64 | NOTUM (0.42) | NOTUMMAPTALDH1A1HTTHPGD | |
| SCHEMBL17694561 | 0.62 | NOTUM (0.78) | NOTUMMAPTALDH1A1HTTHPGD | |
| SCHEMBL539177 | 0.62 | NOTUM (0.41) | NOTUMALDH1A1HPGDTSHRLMNA | |
| SCHEMBL5959922 | 0.61 | NOTUM (0.39) | NOTUMMAPTALDH1A1HTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230015063-A1 | METAL-ASSISTED DELAYED FLUORESCENT EMITTERS CONTAINING TRIDENTATE LIGANDS | UNIV ARIZONA STATE (US) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230015063-A1 | METAL-ASSISTED DELAYED FLUORESCENT EMITTERS CONTAINING TRIDENTATE LIGANDS | SLC30A6, SLC30A5, BRI3BP | NOTUM 2731/4885MAPT 839/4885ALDH1A1 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.